Skip to content
Search

Latest Stories

GPhC proposes new guidance for online pharmacies to improve patient safety

GPhC proposes new guidance for online pharmacies to improve patient safety

These proposed changes aim to address inappropriate supply of high-risk medicines by online pharmacies

The General Pharmaceutical Council (GPhC) is inviting feedback on proposed changes to its guidance for online pharmacies, aimed at enhancing patient safety.


These changes are designed to tackle concerns associated with receiving medicines from online pharmacies, particularly those that may not be clinically appropriate and could potentially harm patients.

GPhC has identified concerns relating to inappropriate supplies of weight loss medications  that could pose risk to patients' health.

Duncan Rudkin, Chief Executive of the GPhC, underscored the importance of addressing risks in online pharmacy services.

“We know that there can be significant benefits for people using online pharmacy services to get medicines and treatment, but there are also additional risks that need to be managed, to make sure medicines and other pharmacy services are provided safely to patients and the public.

“Through our inspections and investigations, we’ve seen significant risks to patient safety when online questionnaires have inappropriately been the only mode of consultation used, and when the information provided by the patient isn’t verified by the prescriber.”

The regulator is seeking views from stakeholders on the following key proposed changes:

  • Online pharmacies will be required to implement additional safety measures when prescribing or supplying medicines known to be associated with greater risks, such as those used for weight loss.
  • There should be a two-way communication channel between the patient and the prescriber for all online prescribing as some medicines are not suitable to be prescribed using an online questionnaire alone.
  • Prescribers will be given further instructions on how to verify patient information, especially for high-risk medicines. This may include conducting a direct consultation through a phone call or video chat, or by contacting the person’s GP.
  • Additional guidance will be provided for prescribers to follow in circumstances where patients lack a regular prescriber or have not consented to share their information with their GP.
  • Superintendent Pharmacists will be made jointly responsible with pharmacy owners for adhering to the new guidance.

Concerns about inappropriate supplies of medicines by online pharmacies were identified through GPhC inspections and enforcement action against online pharmacies, fitness to practise concerns raised with the regulator, and through working closely with other regulators.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less